Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $10.12 billion
- Book Value:
- Revenue TTM:
- $1.71 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $1.24 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Cochlear Limited had its IPO on under the ticker symbol CHEOF.
The company operates in the Healthcare sector and Medical Devices industry. Cochlear Limited has a staff strength of 4,500 employees.
Shares of Cochlear Limited opened at $153.88 at the start of the last trading session i.e. 2023-03-21.
The stocks traded within a range of $153.88 - $153.88, and closed at $153.88.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Cochlear Limited have increased by +2.49%.
Cochlear Limited's Key Ratios
Cochlear Limited has a market cap of $10.12 billion, indicating a price to book ratio of 8.0768 and a price to sales ratio of 5.6886.
In the last 12-months Cochlear Limited’s revenue was $1.71 billion with a gross profit of $1.24 billion and an EBITDA of $394.30 million. The EBITDA ratio measures Cochlear Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cochlear Limited’s operating margin was 20.8% while its return on assets stood at 9.09% with a return of equity of 15.18%.
In Q2, Cochlear Limited’s quarterly earnings growth was a negative -16.4% while revenue growth was a positive 7.9%.
Cochlear Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $2.63 per share while it has a forward price to earnings multiple of 45.6621 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cochlear Limited’s profitability.
Cochlear Limited stock is trading at a EV to sales ratio of 5.489 and a EV to EBITDA ratio of 19.0313. Its price to sales ratio in the trailing 12-months stood at 5.6886.
Cochlear Limited stock pays annual dividends of $1.45 per share, indicating a yield of 1.47% and a payout ratio of 75.47%.
Balance sheet and cash flow metrics
- Total Assets
- $2.47 billion
- Total Liabilities
- $527.60 million
- Operating Cash Flow
- Capital Expenditure
- $11.80 million
- Dividend Payout Ratio
Cochlear Limited ended 2023 with $2.47 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.47 billion while shareholder equity stood at $1.69 billion.
Cochlear Limited ended 2023 with $33.00 million in deferred long-term liabilities, $527.60 million in other current liabilities, 1276600000.00 in common stock, $455.30 million in retained earnings and $257.10 million in goodwill. Its cash balance stood at $629.30 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Cochlear Limited’s total current assets stands at $1.33 billion while long-term investments were $119.10 million and short-term investments were $0. Its net receivables were $390.40 million compared to accounts payable of $232.40 million and inventory worth $270.20 million.
In 2023, Cochlear Limited's operating cash flow was $-29250000.00 while its capital expenditure stood at $11.80 million.
Comparatively, Cochlear Limited paid $0.75 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Cochlear Limited stock is currently trading at $153.88 per share. It touched a 52-week high of $171.2837 and a 52-week low of $171.2837. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $146.71 and 200-day moving average was $151.42 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 49.4% of the company’s stock are held by insiders while 4497.4% are held by institutions.
Frequently Asked Questions About Cochlear Limited
Similar Industry Stocks (Medical Devices)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.